Craniofacial reconstruction as a treatment for elevated intracranial pressure

Lissa Baird, David Gonda, Steven R. Cohen, Lars H. Evers, Nathalie LeFloch, Michael L. Levy, Hal S. Meltzer

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Introduction: Craniofacial procedures may be needed to address symptomatic intracranial hypertension. The authors review their institutional experience in the treatment of children with symptomatic increased intracranial pressure (ICP) utilizing craniofacial reconstructive procedures. Methods: The senior authors' (HSM, SRC) craniofacial experience of 222 patients over a 7-year period from 2000 to 2007 at a single institution (Rady Children's Hospital, San Diego) is reviewed. Seventeen patients were identified who were felt to be candidates for craniofacial surgery with symptomatic increased ICP. Results: Patient diagnoses included single-suture craniosynostosis, craniofacial dysostoses, shunt-induced craniostenosis, and shunt-associated intracranial hypertension (slit-ventricle syndrome). Seventeen patients underwent 21 craniofacial procedures. Age at surgery ranged from 3 months to 13 years with a mean of 5 years. Preoperative symptoms and signs included headaches, unexplained irritability, seizures, papilledema, and visual loss. All patients had diagnostic neuroimaging. Seven patients had preoperative invasive ICP measurements. Surgery was deferred on three of these patients based on these measurements. The mean total operative (including anesthetic preparation) and surgical times were 3 h 12 min and 2 h 20 min, respectively. Percentage operative blood loss averaged 11.3%. In six procedures, no transfusions were required. Average hospital stay was 4 days. There was no perioperative mortality or significant surgery associated morbidity. All patients have had postoperative clinical improvement in signs and symptoms of increased ICP. Conclusions: Using modern diagnostic and surgical techniques, including invasive ICP monitoring, increased intracranial pressure can be successfully managed by an experienced, multidisciplinary, craniofacial team. Our treatment paradigm and operative management scheme is discussed.

Original languageEnglish (US)
Pages (from-to)411-418
Number of pages8
JournalChild's Nervous System
Volume28
Issue number3
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Intracranial Hypertension
Intracranial Pressure
Craniosynostoses
Therapeutics
Signs and Symptoms
Slit Ventricle Syndrome
Surgical Diagnostic Techniques
Craniofacial Dysostosis
Papilledema
Operative Time
Neuroimaging
Sutures
Headache
Anesthetics
Length of Stay
Seizures
Morbidity
Mortality

Keywords

  • Craniofacial reconstruction
  • Craniosynostosis
  • Intracranial hypertension
  • Intracranial pressure monitoring
  • Slit ventricle syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology
  • Medicine(all)

Cite this

Baird, L., Gonda, D., Cohen, S. R., Evers, L. H., LeFloch, N., Levy, M. L., & Meltzer, H. S. (2012). Craniofacial reconstruction as a treatment for elevated intracranial pressure. Child's Nervous System, 28(3), 411-418. https://doi.org/10.1007/s00381-011-1615-6

Craniofacial reconstruction as a treatment for elevated intracranial pressure. / Baird, Lissa; Gonda, David; Cohen, Steven R.; Evers, Lars H.; LeFloch, Nathalie; Levy, Michael L.; Meltzer, Hal S.

In: Child's Nervous System, Vol. 28, No. 3, 2012, p. 411-418.

Research output: Contribution to journalArticle

Baird, L, Gonda, D, Cohen, SR, Evers, LH, LeFloch, N, Levy, ML & Meltzer, HS 2012, 'Craniofacial reconstruction as a treatment for elevated intracranial pressure', Child's Nervous System, vol. 28, no. 3, pp. 411-418. https://doi.org/10.1007/s00381-011-1615-6
Baird, Lissa ; Gonda, David ; Cohen, Steven R. ; Evers, Lars H. ; LeFloch, Nathalie ; Levy, Michael L. ; Meltzer, Hal S. / Craniofacial reconstruction as a treatment for elevated intracranial pressure. In: Child's Nervous System. 2012 ; Vol. 28, No. 3. pp. 411-418.
@article{3fac9c3f7cbd45e888956c3b3b8ddf07,
title = "Craniofacial reconstruction as a treatment for elevated intracranial pressure",
abstract = "Introduction: Craniofacial procedures may be needed to address symptomatic intracranial hypertension. The authors review their institutional experience in the treatment of children with symptomatic increased intracranial pressure (ICP) utilizing craniofacial reconstructive procedures. Methods: The senior authors' (HSM, SRC) craniofacial experience of 222 patients over a 7-year period from 2000 to 2007 at a single institution (Rady Children's Hospital, San Diego) is reviewed. Seventeen patients were identified who were felt to be candidates for craniofacial surgery with symptomatic increased ICP. Results: Patient diagnoses included single-suture craniosynostosis, craniofacial dysostoses, shunt-induced craniostenosis, and shunt-associated intracranial hypertension (slit-ventricle syndrome). Seventeen patients underwent 21 craniofacial procedures. Age at surgery ranged from 3 months to 13 years with a mean of 5 years. Preoperative symptoms and signs included headaches, unexplained irritability, seizures, papilledema, and visual loss. All patients had diagnostic neuroimaging. Seven patients had preoperative invasive ICP measurements. Surgery was deferred on three of these patients based on these measurements. The mean total operative (including anesthetic preparation) and surgical times were 3 h 12 min and 2 h 20 min, respectively. Percentage operative blood loss averaged 11.3{\%}. In six procedures, no transfusions were required. Average hospital stay was 4 days. There was no perioperative mortality or significant surgery associated morbidity. All patients have had postoperative clinical improvement in signs and symptoms of increased ICP. Conclusions: Using modern diagnostic and surgical techniques, including invasive ICP monitoring, increased intracranial pressure can be successfully managed by an experienced, multidisciplinary, craniofacial team. Our treatment paradigm and operative management scheme is discussed.",
keywords = "Craniofacial reconstruction, Craniosynostosis, Intracranial hypertension, Intracranial pressure monitoring, Slit ventricle syndrome",
author = "Lissa Baird and David Gonda and Cohen, {Steven R.} and Evers, {Lars H.} and Nathalie LeFloch and Levy, {Michael L.} and Meltzer, {Hal S.}",
year = "2012",
doi = "10.1007/s00381-011-1615-6",
language = "English (US)",
volume = "28",
pages = "411--418",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Craniofacial reconstruction as a treatment for elevated intracranial pressure

AU - Baird, Lissa

AU - Gonda, David

AU - Cohen, Steven R.

AU - Evers, Lars H.

AU - LeFloch, Nathalie

AU - Levy, Michael L.

AU - Meltzer, Hal S.

PY - 2012

Y1 - 2012

N2 - Introduction: Craniofacial procedures may be needed to address symptomatic intracranial hypertension. The authors review their institutional experience in the treatment of children with symptomatic increased intracranial pressure (ICP) utilizing craniofacial reconstructive procedures. Methods: The senior authors' (HSM, SRC) craniofacial experience of 222 patients over a 7-year period from 2000 to 2007 at a single institution (Rady Children's Hospital, San Diego) is reviewed. Seventeen patients were identified who were felt to be candidates for craniofacial surgery with symptomatic increased ICP. Results: Patient diagnoses included single-suture craniosynostosis, craniofacial dysostoses, shunt-induced craniostenosis, and shunt-associated intracranial hypertension (slit-ventricle syndrome). Seventeen patients underwent 21 craniofacial procedures. Age at surgery ranged from 3 months to 13 years with a mean of 5 years. Preoperative symptoms and signs included headaches, unexplained irritability, seizures, papilledema, and visual loss. All patients had diagnostic neuroimaging. Seven patients had preoperative invasive ICP measurements. Surgery was deferred on three of these patients based on these measurements. The mean total operative (including anesthetic preparation) and surgical times were 3 h 12 min and 2 h 20 min, respectively. Percentage operative blood loss averaged 11.3%. In six procedures, no transfusions were required. Average hospital stay was 4 days. There was no perioperative mortality or significant surgery associated morbidity. All patients have had postoperative clinical improvement in signs and symptoms of increased ICP. Conclusions: Using modern diagnostic and surgical techniques, including invasive ICP monitoring, increased intracranial pressure can be successfully managed by an experienced, multidisciplinary, craniofacial team. Our treatment paradigm and operative management scheme is discussed.

AB - Introduction: Craniofacial procedures may be needed to address symptomatic intracranial hypertension. The authors review their institutional experience in the treatment of children with symptomatic increased intracranial pressure (ICP) utilizing craniofacial reconstructive procedures. Methods: The senior authors' (HSM, SRC) craniofacial experience of 222 patients over a 7-year period from 2000 to 2007 at a single institution (Rady Children's Hospital, San Diego) is reviewed. Seventeen patients were identified who were felt to be candidates for craniofacial surgery with symptomatic increased ICP. Results: Patient diagnoses included single-suture craniosynostosis, craniofacial dysostoses, shunt-induced craniostenosis, and shunt-associated intracranial hypertension (slit-ventricle syndrome). Seventeen patients underwent 21 craniofacial procedures. Age at surgery ranged from 3 months to 13 years with a mean of 5 years. Preoperative symptoms and signs included headaches, unexplained irritability, seizures, papilledema, and visual loss. All patients had diagnostic neuroimaging. Seven patients had preoperative invasive ICP measurements. Surgery was deferred on three of these patients based on these measurements. The mean total operative (including anesthetic preparation) and surgical times were 3 h 12 min and 2 h 20 min, respectively. Percentage operative blood loss averaged 11.3%. In six procedures, no transfusions were required. Average hospital stay was 4 days. There was no perioperative mortality or significant surgery associated morbidity. All patients have had postoperative clinical improvement in signs and symptoms of increased ICP. Conclusions: Using modern diagnostic and surgical techniques, including invasive ICP monitoring, increased intracranial pressure can be successfully managed by an experienced, multidisciplinary, craniofacial team. Our treatment paradigm and operative management scheme is discussed.

KW - Craniofacial reconstruction

KW - Craniosynostosis

KW - Intracranial hypertension

KW - Intracranial pressure monitoring

KW - Slit ventricle syndrome

UR - http://www.scopus.com/inward/record.url?scp=84860862904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860862904&partnerID=8YFLogxK

U2 - 10.1007/s00381-011-1615-6

DO - 10.1007/s00381-011-1615-6

M3 - Article

C2 - 22068642

AN - SCOPUS:84860862904

VL - 28

SP - 411

EP - 418

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 3

ER -